Global healthcare analytical testing services market is anticipated to grow at a significant CAGR of 13.1% during the forecast period (2024-2031). The market growth is attributed to the increasing number of clinical trials that require analytical testing with outsourcing of analytical testing services by pharmaceutical companies globally driving the growth of the market. The pharmaceutical, biotechnology, and medical device manufacturing companies frequently use healthcare analytical testing services to help with various phases of drug development. This program assists with medication development processes ranging from discovery through clinical trials to the point at which pharmaceuticals are used commercially by humans. For instance, in August 2023, Eurofins Scientific SE announced that provides a unique range of analytical testing services to the pharmaceutical, food, environmental, and consumer products industries in India. Eurofins Advinus also supports various analytical, toxicology, and chemistry services for regulatory submission requirements of other industries such as agrochemicals, cosmetics, nutraceuticals, and industrial chemicals.
Browse the full report description of “Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report by Type (Bioanalytical Testing Services, Physical Characterization Services, Method Development & Validation Services, Raw Material Testing Services, Batch- Release Testing Services, and Others (Stability Testing Services, Genomics Testing Services).and by End-Users (Pharmaceuticals, Hospitals and Clinics and Forensic Lab). Forecast Period (2024-2031).” at https://www.omrglobal.com/industry-reports/healthcare-analytical-testing-services-market
Analytical testing services support in development, characterization, and CGMP testing is critical for innovators across the biologics pipeline, with delays affecting the overall time to get new drugs into the clinic, and ultimately to patients. For instance, in October 2022, Catalent, Inc. announced a $12.0 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri. The project involves two new analytical development laboratories to support the growing demands of assay development for both traditional biologic and advanced biologic modality programs.
Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. Market players responding to global demand for biosafety testing for drug development and commercialization. For instance, in May 2023, Merck KGaA invested €35.0 million ($37.8 million) in biosafety testing at its Glasgow and Stirling sites, in Scotland. The company will expand testing capacity in its current buildings with biosafety testing, analytical development, and viral clearance suites.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Type
o By End-Users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Catalent, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, Medpace, Inc., and, Merck KGaA, among others.
Key questions addressed by the report.
Global Healthcare Analytical Testing Services Market Report Segment
By Type
By End-Users
Global Healthcare Analytical Testing Services Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/healthcare-analytical-testing-services-market